Leverette

Ethinylestradiol, the active ingredient in Leverette, is a combined oral contraceptive presented as a tablet for oral use. It works together with levonorgestrel to prevent pregnancy in women of reproductive age. The formulation also includes levonorgestrel, a synthetic progestogen, providing a synergistic effect that enhances contraceptive reliability.

GNH USA supplies Leverette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across all markets.

Leverette, a combined oral contraceptive, is indicated for conditions related to reproductive hormone regulation.

- Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Menstrual cycle regulation: helps achieve regular menstrual bleeding patterns. - Acne treatment: may improve acne associated with hormonal fluctuations.

Leverette may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional mild to moderate pain. - Breakthrough bleeding: spotting between periods. - Mood changes: irritability or mood swings. - Weight gain: slight increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins. - Arterial thrombosis: clot formation in arteries leading to heart attack or stroke. - Severe hypertension: markedly elevated blood pressure. - Liver tumor: benign hepatic adenoma. - Anaphylaxis: severe allergic reaction requiring immediate medical attention.

When prescribing Leverette, clinicians should observe several precautionary measures to ensure patient safety.

- Assess cardiovascular risk: evaluate history of thrombosis before initiating therapy. - Screen smoking status: avoid use in women over 35 who smoke. - Review hepatic function: adjust or avoid in patients with active liver disease. - Consider drug interactions: monitor concomitant use of enzyme‑inducing agents. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Leverette can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness. - Rifampin: decreases hormone levels, increasing risk of unintended pregnancy. - St. John’s wort: can lower plasma concentrations of the active hormones.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline): may slightly diminish contraceptive efficacy. - Antifungals (e.g., fluconazole): may increase hormone levels, raising side‑effect risk. - Herbal supplements (e.g., ginseng): may affect hormone metabolism and require monitoring.